Cargando…

The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling

IL-17A is a central driver of spondyloarthritis (SpA), its production was originally proposed to be IL-23 dependent. Emerging preclinical and clinical evidence suggests, however, that IL-17A and IL-23 have a partially overlapping but distinct biology. We aimed to assess the extent to which IL-17A-dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Tok, Melissa N., Na, Songqing, Lao, Christopher R., Alvi, Marina, Pots, Desirée, van de Sande, Marleen G. H., Taurog, Joel D., Sedgwick, Jonathon D., Baeten, Dominique L., van Duivenvoorde, Leonie M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046377/ https://www.ncbi.nlm.nih.gov/pubmed/30038617 http://dx.doi.org/10.3389/fimmu.2018.01550

Ejemplares similares

Innate Immune Activation Can Trigger Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats
por: van Tok, Melissa N., et al.
Publicado: (2017)

mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation in vitro and in vivo
por: Chen, Sijia, et al.
Publicado: (2020)

Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue
por: Rysnik, Oliwia, et al.
Publicado: (2016)

Paradoxical Augmentation of Experimental Spondyloarthritis by RORC Inhibition in HLA-B27 Transgenic Rats
por: van Tok, Melissa N., et al.
Publicado: (2021)

Data showing non-conventional HLA-B27 expression in axial joints and gut tissue from B27 transgenic rats, and in frozen and paraffin-fixed synovial SpA tissue
por: Rysnik, Oliwia, et al.
Publicado: (2016)

Relative overexpression of membrane-bound versus soluble TNF in spondyloarthritis
por: Ambarus, Carmen A, et al.
Publicado: (2012)

Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis
por: Hammoura, Ihsan, et al.
Publicado: (2022)

Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis
por: Kaaij, Merlijn H., et al.
Publicado: (2020)

Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort
por: de Winter, Janneke J., et al.
Publicado: (2018)

Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis
por: de Winter, Janneke J, et al.
Publicado: (2019)

The Role of the IL-23/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models
por: Mandour, Mohamed, et al.
Publicado: (2021)

Expansion of Interleukin‐22– and Granulocyte–Macrophage Colony‐Stimulating Factor–Expressing, but Not Interleukin‐17A–Expressing, Group 3 Innate Lymphoid Cells in the Inflamed Joints of Patients With Spondyloarthritis
por: Blijdorp, Iris C. J., et al.
Publicado: (2019)

Progression From Subclinical Inflammation to Overt Spondyloarthritis in First‐Degree Relatives of Patients in Association With HLA–B27: The Pre‐Spondyloarthritis Cohort
por: de Jong, Henriëtte M. Y., et al.
Publicado: (2022)

Anti-IL-17A treatment reduces serum inflammatory, angiogenic and tissue remodeling biomarkers accompanied by less synovial high endothelial venules in peripheral spondyloarthritis
por: Kaaij, Merlijn H., et al.
Publicado: (2020)

Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis
por: Cañete, Juan D., et al.
Publicado: (2015)

Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain
por: de Winter, Janneke, et al.
Publicado: (2018)

IL-17 in spondyloarthritis: is the T-party over?
por: Yeremenko, Nataliya, et al.
Publicado: (2011)

Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis
por: de Winter, Janneke J., et al.
Publicado: (2016)

Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis
por: Wang, Runsheng, et al.
Publicado: (2021)

Insulin-Like Growth Factor I Does Not Drive New Bone Formation in Experimental Arthritis
por: van Tok, Melissa N., et al.
Publicado: (2016)

Patients’ and rheumatologists’ perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

Measuring quality of life of patients with axial spondyloarthritis for economic evaluation
por: Hernandez Alava, Monica, et al.
Publicado: (2022)

Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort
por: Turina, Maureen C, et al.
Publicado: (2017)

Evaluation of multiple referral strategies for axial spondyloarthritis in the SPondyloArthritis Caught Early (SPACE) cohort
por: Abawi, Ozair, et al.
Publicado: (2017)

Age at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study
por: Boel, Anne, et al.
Publicado: (2021)

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis
por: Paramarta, Jacqueline E, et al.
Publicado: (2011)

Hyaluronic Acid in Synovial Fluid Prevents Neutrophil Activation in Spondyloarthritis
por: Mol, Sanne, et al.
Publicado: (2023)

An add-on training program involving breathing exercises, cold exposure, and meditation attenuates inflammation and disease activity in axial spondyloarthritis – A proof of concept trial
por: Buijze, G. A., et al.
Publicado: (2019)

Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients
por: van den Brandt, Stephanie, et al.
Publicado: (2017)

Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis
por: Braun, Juergen, et al.
Publicado: (2023)

Identification of robust and disease-specific stromal alterations in spondyloarthritis synovitis
por: Yeremenko, Nataliya, et al.
Publicado: (2011)

Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort
por: Ortolan, Augusta, et al.
Publicado: (2018)

IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt
por: Fiechter, Renée H., et al.
Publicado: (2021)

Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?
por: van Lunteren, Miranda, et al.
Publicado: (2019)

A psychometric analysis of outcome measures in peripheral spondyloarthritis
por: Turina, Maureen C, et al.
Publicado: (2016)

Serum biomarkers to predict clinical response in proof-of-concept trials in spondyloarthritis
por: Turina, Maureen, et al.
Publicado: (2011)

Mechanistic rationales for targeting interleukin-17A in spondyloarthritis
por: Raychaudhuri, Siba P., et al.
Publicado: (2017)

Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis
por: Barthel, Christian, et al.
Publicado: (2009)

Adalimumab serum levels and antidrug antibodies towards adalimumab in peripheral spondyloarthritis: no association with clinical response to treatment or with disease relapse upon treatment discontinuation
por: Paramarta, Jacqueline E, et al.
Publicado: (2014)

A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis
por: Paramarta, Jacqueline E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ca4ro3adc9lgg6apgts79s58jj